2011 ACRIN Annual Meeting Cost-Effectiveness of Screening in the National Lung Screening Trial William C. Black, MD Dartmouth-Hitchcock Medical Center.

Slides:



Advertisements
Similar presentations
Please note, these are the actual video-recorded proceedings from the live CME event and may include the use of trade names and other raw, unedited content.
Advertisements

US cost-effectiveness of simvastatin in 20,536 people at different levels of vascular disease risk: randomised placebo-controlled trial UK Medical Research.
COURAGE Economic Results of the COURAGE Trial William S. Weintraub, MD Chief of Cardiology Christiana Care Health System Professor of Medicine, Thomas.
Raanan Shamir, MD Cost Effectiveness of Population Screening
Assessing Health and Economic Outcomes for Diagnostic Imaging William C. Black, M.D. Dartmouth-Hitchcock Medical Center.
The Practice of Cost- Effectiveness Analysis: Designing, Conducting and Interpreting CEA under Non-Ideal Circumstances The Practice of Cost- Effectiveness.
Economic Analysis and Management Todd Wagner, PhD.
Recommendations for Conducting Cost Effectiveness: Elements of the Reference Case Ciaran S. Phibbs, Ph.D. February 25, 2009.
Matthew R. Reynolds, M.D., M.Sc. On Behalf of the PARTNER Investigators Lifetime Cost Effectiveness of Transcatheter Aortic Valve Replacement Compared.
Analysis Alongside A Randomized Trial Todd Wagner, PhD May 2009.
Cost-effectiveness Analysis: A practical primer Eran Bendavid.
Cost-Effectiveness of Transcatheter Aortic Valve Replacement with a Self-Expanding Prosthesis Compared with Surgical Aortic Valve Replacement in High Risk.
Sharp L, Tilson L, Whyte S, Ó Céilleachair A
Cost-effectiveness of converting non- sedating antihistamines from prescription to over-the-counter status Michael B. Nichol, Ph.D. Patrick Sullivan, Ph.D.
Cost Effectiveness of CT Screening in the National Lung Screening Trial William C. Black, M.D. Dartmouth-Hitchcock Medical Center NLST CEA Writing Team.
Assessing Health and Economic Outcomes William C. Black, M.D. Director ACRIN Outcomes & Economics Core Laboratory Dartmouth-Hitchcock Medical Center.
Cost-Effectiveness Problem l You have a $1.5 billion budget to spend on any combination of these programs:
Economics of Implementation: Moving beyond Traditional CEA Mark Smith Paul Barnett VA Health Economics Resource Center.
TACTICS-TIMI 18 Economics & HRQOL Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy.
Taxes on the Longevity Dividend: Can we Reduce Them? Lessons from the Theoretical Foundations of Medical Cost-Effectiveness Analysis David Meltzer MD,
These slides were released by the speaker for internal use by Novartis.
Finding N.E.M.O. Marvin R. Balaan, MD, FCCP System Division Director, Division of Pulmonary and Critical Care Medicine Allegheny Health Network, Pittsburgh.
Types of analysis. Simulation rationale u Each patient’s natural history is random, but guided by underlying parameters. u With sufficiently large number.
The Cost-Effectiveness of Computer-Assisted Navigation in Total Knee Arthroplasty by Erik J. Novak, Marc D. Silverstein, and Kevin J. Bozic J Bone Joint.
Implications of lung cancer screening in the new millenia Andrew R. Haas, MD, PhD Assistant Professor of Medicine Section of Interventional Pulmonary and.
IAS July The Development of AntiRetroviral Therapy in Africa (DART) trial Cost Effectiveness Analysis of Routine Laboratory or Clinically Driven.
Economics of Implementation: Moving beyond Traditional CEA Mark Smith Paul Barnett VA Health Economics Resource Center.
Cost-Effectiveness and Cost-Benefit Analysis N287E Spring 2006 Joanne Spetz 31 May 2006.
Validation / citations. Validation u Expert review of model structure u Expert review of basic code implementation u Reproduce original inputs u Correctly.
Evidence, HTA and Comparative Effectiveness in the U.S. Presentation at AMCP March 28, 2007 Peter J. Neumann Tufts-New England Medical Center.
Economic evaluation of psychotherapy for personality disorders: burden of disease and cost-effectiveness Djøra Soeteman Viersprong Institute for Studies.
{ Challenges in cost-utility analysis in the critical care setting Ville Pettilä MD, PhD, A/P Helsinki University Hospital VP SFAI- veckan.
RESCUE: Assessing Health and Economic Outcomes William C. Black, M.D. Dartmouth-Hitchcock Medical Center.
How Can Cost Effectiveness Analysis Be Made More Relevant to U.S. Health Care? Paul G. Barnett, PhD February 29, 2012.
ALLHAT Cost-effectiveness in the ALLHAT Antihypertensive Trial Heidenreich P A, et al. J Gen Intern Med 23(5):509–16.
Aug 1, Conducting Cost-Effectiveness Analyses of Behavioral Interventions Todd H. Wagner, Ph.D. Mary K. Goldstein, M.D. Mary K. Goldstein, M.D.
Implications of lung cancer screening in the new millenia Andrew R. Haas, MD, PhD Assistant Professor of Medicine Section of Interventional Pulmonary and.
Hospital Safety: Do race and ethnicity matter? Ernest Moy, MD, MPH Elizabeth Dayton, MA Roxanne Andrews, PhD The Agency for Healthcare Research and Quality.
EQ-5D and SF-36 Quality of Life Measures in Systemic Lupus Erythematosus: Comparisons with RA, Non-Inflammatory Disorders (NIRD), and Fibromyalgia (FM)
Tolerability of Breast Cancer Screening, Diagnostic and Biopsy Procedures: An ACRIN 6666 Substudy Mark D. Schleinitz, MD, MS Dina DePalo Jeffrey Blume,
Lung Cancer Screening: Benefits and limitations to its Implementation
♦ Data Source : Blue Cross Blue Shield of Texas (BCBSTX), and Medicaid Texas 2008 – 2012 administrative data ♦ Population: Women aged 12 – 55 at the time.
Cost-Effectiveness and Outcomes Research Setting value to what we do.
BIOE 301 Lecture Sixteen. Review of Lectures What is the goal of cancer screening? Successful cancer screening examples? Can screening hurt more.
● The results of this study suggest that using the prognostic test to guide ACT decisions in NSCLC is cost-effective compared to a SoC approach according.
Date of download: 5/28/2016 From: Benefits and Harms of Computed Tomography Lung Cancer Screening Strategies: A Comparative Modeling Study for the U.S.
CT Screening for Lung Cancer vs. Smoking Cessation: A Cost-Effectiveness Analysis Pamela M. McMahon, PhD; Chung Yin Kong, PhD; Bruce E. Johnson; Milton.
Date of download: 5/31/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Incremental Cost-effectiveness of Combined Therapy.
Date of download: 6/1/2016 From: Cost-Effectiveness of Novel Regimens for the Treatment of Hepatitis C Virus Ann Intern Med. 2015;162(6): doi: /M
Hannah Weir, PhD Chunyu Li, MD, PhD Division of Cancer Prevention and Control Centers for Disease Control and Prevention, USA North American Association.
Diabetic Retinopathy Clinical Research Network
Occluded Artery Trial: 1° Hypothesis and Design 1° Hypothesis: Late PCI to open occluded IRA will ↓ death/reinfarction/class IV CHF by 25% compared to.
‘PhysioDirect’ for patients with MSK problems ECONOMIC MODEL OVERVIEW.
US cost-effectiveness of simvastatin in 20,536 people at different levels of vascular disease risk: randomised placebo-controlled trial UK Medical Research.
Introduction Out-of-hospital cardiac arrest (OHCA) is the sudden cessation of the heart in an out of hospital setting. In the United States, the incidence.
Adnan K. Chhatriwalla, MD Saint-Luke’s Mid America Heart Institute
Volume 18, Issue 2, Pages (March 2015)
OFEV® (nintedanib) efficacy
Jan B. Pietzsch1, Benjamin P. Geisler1, Murray D. Esler 2
For a copy of the poster:
Markov model structure
Mechanical thrombectomy
Background & Objectives
More Than Survival: Futility
Impact of Cognitive Function Change on Mortality in Renal Transplant and End-Stage Renal Disease Patients Sharma et al. Am J Nephrol 2016;44: (DOI: / )
Jordan B. King et al. JCHF 2016;4:
Increased Mortality at Low-Volume Orthotopic Heart Transplantation Centers: Should Current Standards Change?  Eric S. Weiss, MD, Robert A. Meguid, MD,
Presentation Developed for the Academy of Managed Care Pharmacy
Probabilistic sensitivity analysis.
Diabetic Retinopathy Clinical Research Network
Presentation transcript:

2011 ACRIN Annual Meeting Cost-Effectiveness of Screening in the National Lung Screening Trial William C. Black, MD Dartmouth-Hitchcock Medical Center

2011 ACRIN Annual Meeting Working Group

2011 ACRIN Annual Meeting NLST CEA Comparison: LDCT vs CXR vs None Effectiveness: LYs and QALYs Costs: $US (reference 2009) Perspective: Societal Time horizon: Within-trial and lifetime Discount rate: 3%.

2011 ACRIN Annual Meeting Effectiveness Aggregate LYs from entry to death Observed survival before 2009 Projected survival after 2009 –age, sex, lung ca stage, smoking

2011 ACRIN Annual Meeting Effectiveness (cont) Adjust LYs for QOL (0-1.0) SF-6D utility scoring Estimate missing scores –age, sex, scr, lung ca Brazier et al. JHE 2002; 21:271-92

2011 ACRIN Annual Meeting Costs Direct medical (screening, dx, rx) Non-medical (travel, lodging) Opportunity (lost wages) Projected beyond age, sex, and lung ca stage

2011 ACRIN Annual Meeting Direct Medical Costs Utilization based on med abstraction Estimate/ impute missing utilization Multiply by Medicare prices

2011 ACRIN Annual Meeting ICER = ∆COSTS ∆QALYS

2011 ACRIN Annual Meeting Baseline Results LYs, QALYs & Costs ICERs Subset analyses –age, sex, smok hx, co-morbidity

2011 ACRIN Annual Meeting Hypothetical Baseline Results

2011 ACRIN Annual Meeting Uncertainty Sensitivity analysis Scatter plot of ICE CE Acceptability curves

2011 ACRIN Annual Meeting Incremental Cost Incremental Effect IIIB IV IIIA IA IIIB K Black WC. Med Decis Making 1990;10:212-4

2011 ACRIN Annual Meeting Accomplishments Developed analytic approach using R Completed analysis of “enriched” DHMC subset Developed plan for managing missing data Obtained approval to reuse Medicare data Developed algorithms for projecting survival Selected relevant CPT and DRG codes.

2011 ACRIN Annual Meeting Next Steps Estimate Medicare payments for DRGs Extract utilization and QOL from ACRIN dataset Analyze Medicare data & adjust cost estimates Impute and/or estimate missing data elements Analyze completed NLST CEA dataset in R Write up results and submit.

2011 ACRIN Annual Meeting Use this slide for graphics or images requiring a larger space

2011 ACRIN Annual Meeting Use this slide for text only Keep number of points to six of fewer per slide